Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATELYN E LYNCH

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1194977330
CMS profile
10442202
Location
LANSING, MI

General Payments · PY2021–2024

$10,892.13

  • Reported across 88 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$333.47

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $303.50 12
Long term medical supply or device loan $29.97 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Tandem Diabetes Care, Inc. $87.17 2
Medtronic, Inc. $54.65 1
Abbott Laboratories $49.22 2
Bayer HealthCare Pharmaceuticals Inc. $36.86 2
Insulet Corporation $33.91 2
Amgen Inc. $21.20 1
Lilly USA, LLC $18.20 1
IBSA Pharma Inc. $16.76 1
CeQur Corporation $15.50 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $1,765.24 18
PY2022 $6,619.97 30
PY2023 $2,173.45 27
PY2024 $333.47 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $19.25 06/27/2024 Food and Beverage Undisputed 01/23/2026 1124896171 CMS
Abbott Laboratories $29.97 08/08/2024 Long term medical supply or device loan Undisputed 01/23/2026 1125394732 CMS
Amgen Inc. $21.20 02/19/2024 Food and Beverage Undisputed 01/23/2026 1117315570 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.43 04/17/2024 Food and Beverage Undisputed 01/23/2026 1086343227 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.43 10/28/2024 Food and Beverage Undisputed 01/23/2026 1086366747 CMS
CeQur Corporation $15.50 04/15/2024 Food and Beverage Undisputed 01/23/2026 1099648969 CMS
IBSA Pharma Inc. $16.76 04/09/2024 Food and Beverage Undisputed 01/23/2026 1142981757 CMS
Insulet Corporation $17.41 09/10/2024 Food and Beverage Undisputed 01/23/2026 1116809809 CMS
Insulet Corporation $16.50 11/25/2024 Food and Beverage Undisputed 01/23/2026 1116823614 CMS
Lilly USA, LLC $18.20 01/24/2024 Food and Beverage Undisputed 01/23/2026 1135724949 CMS
Medtronic, Inc. $54.65 07/10/2024 Food and Beverage Undisputed 01/23/2026 1116917117 CMS
Tandem Diabetes Care, Inc. $18.03 05/10/2024 Food and Beverage Undisputed 01/23/2026 1138746323 CMS
Tandem Diabetes Care, Inc. $69.14 08/28/2024 Food and Beverage Undisputed 01/23/2026 1138750843 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.